Results 1 - 6 of 6 (Click here to explore results)

Small-molecule inhibitors of HIF-PHD2: a valid strategy to renal anemia treatment in clinical therapy. Yue Wu, Nan Wang, Yonghua Lei, Tianhan Hu, Qidong You, Xiaojin Zhang , Med. Chem. Commun. , 2016 , 7 , 1271

Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials. Tzu-Lan Yeh, Thomas M. Leissing, Martine I. Abboud, Cyrille C. Thinnes, Onur Atasoylu, James P. Holt-Martyn, Dong Zhang, Anthony Tumber, Kerstin Lippl, Christopher T. Lohans, Ivanhoe K. H. Leung, Helen Morcrette, Ian J. Clifton, Timothy D. W. Claridge, Akane Kawamura, Emily Flashman, Xin Lu, Peter J. Ratcliffe, Rasheduzzaman Chowdhury, Christopher W. Pugh, Christopher J. Schofield , Chem. Sci. , 2017 , 8 , 7651

A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation. Zhihong Li, Shuai Zhen, Kaijun Su, Anthony Tumber, Quanwei Yu, Ying Dong, Michael McDonough, Christopher J. Schofield, Xiaojin Zhang , Chem. Commun. , 2020 , 56 , 14199

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5. Anthony Tumber, Eidarus Salah, Lennart Brewitz, Thomas P. Corner, Christopher J. Schofield , RSC Chem. Biol. , 2023

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors. James P. Holt-Martyn, Anthony Tumber, Mohammed Z. Rahman, Kerstin Lippl, William Figg, Michael A. McDonough, Rasheduzzaman Chowdhury, Christopher J. Schofield , Med. Chem. Commun. , 2019 , 10 , 500

Evaluating and clustering retrosynthesis pathways with learned strategy. Yiming Mo, Yanfei Guan, Pritha Verma, Jiang Guo, Mike E. Fortunato, Zhaohong Lu, Connor W. Coley, Klavs F. Jensen , Chem. Sci. , 2021 , 12 , 1469